Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Solid Tumors × Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 26 Carcinoma, Non-Small-Cell Lung 19 Breast Neoplasms 18 Rectal Neoplasms 15 Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Glioblastoma 14 Esophageal Squamous Cell Carcinoma 14 Lung Neoplasms 13 Head and Neck Neoplasms 11 Esophageal Neoplasms 11 Uterine Cervical Neoplasms 8 Nasopharyngeal Carcinoma 8 Glioma 8 Radiation Injuries 7 Oropharyngeal Neoplasms 7 Stomach Neoplasms 6 Small Cell Lung Carcinoma 6 Neoplasm Metastasis 6 Pancreatic Neoplasms 5 Oligodendroglioma 5 Hyperthermia 5 Carcinoma, Hepatocellular 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Colorectal Neoplasms 4 Astrocytoma 4 Advanced NSCLC 4 NSCLC 3

Interventions

Injections 11 Bevacizumab 7 pembrolizumab 6 Leucovorin 5 Fluorouracil 5 Oxaliplatin 4 Carboplatin 4 Pemetrexed 3 Paclitaxel 3 Docetaxel 3 Capecitabine 3 trifluridine tipiracil drug combination 2 fludarabine 2 Irinotecan 2 Fulvestrant 2 Cyclophosphamide 2 Cisplatin 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 toripalimab 1 tislelizumab 1 sacituzumab govitecan 1 palbociclib 1 osimertinib 1 olaparib 1 lazertinib 1 fluzoparib 1 cemiplimab 1 Sirolimus 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06368960 2024-04-16

BM201-1001

InnoBM Pharmaceuticals Co., Ltd.

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡